Skip to content

Shiwei Wenshen Pill combined with low-dose tadalafil in the treatment of erectile dysfunction due to kidney deficiency and liver stagnation

Shiwei Wenshen Pill combined with low-dose tadalafil in the treatment of erectile dysfunction due to kidney deficiency and liver stagnation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062071
Enrollment
Unknown
Registered
2022-07-21
Start date
2022-07-25
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

erectile dysfunction

Interventions

Control group:Tadalafil tablets
Experimental group:Shiwei Wenshen Pill + Tadalafil Tablets

Sponsors

The First Affiliated Hospital of He'nan University of CM
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Impotence patients who meet the diagnostic criteria of Western medicine and TCM syndromes; 2. Married cohabitation or unmarried sexual partners are fixed and can have regular sex life; 3. Age between 20 and 60 years old; 4. The spouse or sexual partner has no serious organic disease; 5. No other drugs for impotence were taken within 3 months.

Exclusion criteria

Exclusion criteria: 1. Drug-induced and traumatic ED patients; 2. The spouse has a serious organic disease; 3. Combined with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, nervous system diseases, and endocrine diseases; 4. Those who did not meet the inclusion criteria and did not take medication as prescribed, which would affect the judgment of efficacy and safety.

Design outcomes

Primary

MeasureTime frame
international index of erectile function, IIEF-5;TCM syndrome score;

Secondary

MeasureTime frame
Erection Quality Scale;Depression Self-Assessment Tool;

Countries

China

Contacts

Public ContactZulong Wang

The First Affiliated Hospital of He'nan University of CM

z13092365128@163.com+86 15836897159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026